WO2004047761A3 - Genes mbcat en tant que modificateurs de la voie beta-catenine et leurs procedes d'utilisation - Google Patents
Genes mbcat en tant que modificateurs de la voie beta-catenine et leurs procedes d'utilisation Download PDFInfo
- Publication number
- WO2004047761A3 WO2004047761A3 PCT/US2003/037722 US0337722W WO2004047761A3 WO 2004047761 A3 WO2004047761 A3 WO 2004047761A3 US 0337722 W US0337722 W US 0337722W WO 2004047761 A3 WO2004047761 A3 WO 2004047761A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beta
- methods
- mbcats
- modifiers
- catenin pathway
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003295928A AU2003295928A1 (en) | 2002-11-25 | 2003-11-24 | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42886802P | 2002-11-25 | 2002-11-25 | |
US60/428,868 | 2002-11-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004047761A2 WO2004047761A2 (fr) | 2004-06-10 |
WO2004047761A3 true WO2004047761A3 (fr) | 2005-03-24 |
Family
ID=32393471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/037722 WO2004047761A2 (fr) | 2002-11-25 | 2003-11-24 | Genes mbcat en tant que modificateurs de la voie beta-catenine et leurs procedes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003295928A1 (fr) |
WO (1) | WO2004047761A2 (fr) |
-
2003
- 2003-11-24 AU AU2003295928A patent/AU2003295928A1/en not_active Abandoned
- 2003-11-24 WO PCT/US2003/037722 patent/WO2004047761A2/fr not_active Application Discontinuation
Non-Patent Citations (4)
Title |
---|
LEPORCELET M. ET AL: "Small-Molecule Antagonists of the Oncogenic Tcf/Beta-Catenin Protein Complex", CANCER CELL, vol. 5, no. 1, January 2004 (2004-01-01), pages 91 - 102, XP002984831 * |
PARK C.S. ET AL: "Modulation of Beta-Catenin Phospharylation/Degradation by Cyclin-Dependent Kinase 2", J. BIOL. CHEM., vol. 279, no. 19, 7 May 2004 (2004-05-07), pages 19592 - 19599, XP002984830 * |
WONG S.C. ET AL: "Nuclear Beta Catenin as a Potential Prognostic and Diagnostic Marker in Patients with Colorectal Cancer from Hong Kong", MOL. PATHOL., vol. 56, no. 6, December 2003 (2003-12-01), pages 347 - 352, XP002984833 * |
WONG S.C. ET AL: "Prognostic and diagnostic significance of beta-catenin nuclear immunostatin in colorectal cancer", CLIN. CANCER RES., vol. 10, no. 4, 15 February 2004 (2004-02-15), pages 1401 - 1408, XP002984832 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003295928A8 (en) | 2004-06-18 |
AU2003295928A1 (en) | 2004-06-18 |
WO2004047761A2 (fr) | 2004-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003083047A3 (fr) | Genes mp53 en tant que modificateurs de la voie des proteines p53 et methodes d'utilisation | |
WO2002099056A3 (fr) | C22c7orf comme modificateurs de la voie p53 et methodes d'utilisation associees | |
WO2002099074A3 (fr) | Slc7s utilises en tant que modificateurs de la voie p53 et procedes d'utilisation correspondants | |
WO2005016287A3 (fr) | Prkwnk utilises en tant que modificateurs de la voie rac et methodes d'utilisation associees | |
WO2003051905A3 (fr) | Taojik utilises en tant que modificateurs de la voie beta-catenine et procedes d'utilisation associes | |
WO2002099043A3 (fr) | P5crs identifies comme des modificateurs de la voie p53 et procedes d'utilisation | |
WO2004013309A3 (fr) | Papss comme modificateurs de la voie d'axin et procédés d'utilisation | |
WO2004024882A3 (fr) | Flj20647 utilise en tant que modificateur de la voie p21 et procedes d'utilisation associes | |
EP1438432A4 (fr) | Lrrcaps en tant que modificateurs de la voie de passage p53 et leurs procedes d'utilisation | |
WO2005017121A3 (fr) | Mbcats modificateurs de la voie beta-catenine et methodes d'utilisation | |
WO2004014301A3 (fr) | Genes psmc utilises comme modificateurs du trajet retiniblastome (rb) et techniques d'utilisation | |
WO2003074725A3 (fr) | Mbcat comme modificateurs du mecanisme d'action de la $g(b)-catenine et procedes d'utilisation correspondants | |
WO2004061123A3 (fr) | Mbcat servant de modificateurs de la voie de beta-catenine et leurs procedes d'utilisation | |
WO2004015071A3 (fr) | Genes csnk1gs utilises en tant que modificateurs de la voie p21 et procede d'utilisation associe | |
WO2004048538A3 (fr) | Caseine kinases modifiant la voie rac et leurs procedes d'utilisation | |
WO2004083389A3 (fr) | Genes mbcat utilises comme modificateurs de la voie de la beta-catenine et techniques d'utilisation | |
WO2005017123A3 (fr) | Mptens utilises comme modificateurs de la voie pten et procedes d'utilisation | |
WO2004065542A3 (fr) | Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation | |
WO2003052068A3 (fr) | Genes mbcat agissant comme modificateurs du mecanisme d'action de la beta-catenine et methodes d'utilisation | |
WO2004048541A3 (fr) | Cct6 utilises comme modificateurs de la voie rb, et procedes d'utilisation correspondants | |
WO2003074671A3 (fr) | Mbcat tenant lieu de modificateurs de la voie d'une beta-catenine et leurs procedes d'utilisation | |
WO2004047761A3 (fr) | Genes mbcat en tant que modificateurs de la voie beta-catenine et leurs procedes d'utilisation | |
WO2003074673A3 (fr) | Lgals tenant lieu de modificateurs de la voie de chk et leurs procedes d'utilisation | |
WO2003074677A3 (fr) | Mchk comme modulateurs du mecanisme d'action de chk et procedes d'utilisation | |
WO2004083447A3 (fr) | Mbcat en tant que modificateurs de la voie de la beta-catenine et methodes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |